By performing intersection analysis on 35 cervical cancer prognosis related genes and RA differential genes, a total of 3 co-upregulated differential genes were identified (Figure 5a), namely SPP1, LYZ, and MCM5, which were upregulated in patients with rheumatoid arthritis and cervical cancer. The gene discussed is LYZ; the disease is rheumatoid arthritis.